Transaction Update: Ohio Water Development Authority ? Series 2008-B Apr 12

  • ID: 2163559
  • April 2012
  • Region: Ohio
  • Standard & Poors
1 of 3

On April 2, 2012, Standard & Poor's Ratings Services raised its rating on Ohio Water Development Authority's pollution control revenue refunding bonds series 2008-B (for the FirstEnergy Generation project) due Oct. 1, 2018, to 'AA+/A-1+' from 'BBB-' following the addition of a letter of credit (LOC) from The Bank of Nova Scotia N.A. ('AA-/A-1+'). The 'AA+/A-1+' rating reflects our opinion of the joint support that Bank of Nova Scotia and FirstEnergy Generation Corp. (First Energy Generation; 'BBB-') provide in the form of an irrevocable direct-pay LOC and a loan agreement, respectively. Under the LOC, Bank of Nova Scotia fully supports all bond payment obligations when the bonds are in a daily or weekly interest rate reset mode. Therefore, our rating...

Companies mentioned in this report are: Ohio Wtr Dev Auth
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Ohio Wtr Dev Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our


Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.